ScholarIQanswers from OpenAlex

Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease

PaperCitations, authors & open-access status

Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease have?

ScholarIQcitation count

Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease has 280 citations in the OpenAlex counts ScholarIQ stores.

When was Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease published?

ScholarIQyear

Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease has 2004 year in the ScholarIQ index.

What is the open-access status of Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease?

ScholarIQoa status

Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease has closed oa status in the ScholarIQ index.

What is the DOI of Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease?

ScholarIQdoi

The DOI for Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease is on the source record.

What is the PMID of Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease?

ScholarIQpmid

The PMID for Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease is on the source record.

What is the OpenAlex record for Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease?

ScholarIQopenalex

The OpenAlex for Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial